{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:41:33Z","timestamp":1787020893939,"version":"build-2736575974"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T00:00:00Z","timestamp":1697241600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T00:00:00Z","timestamp":1697241600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100007181","name":"Quality Enhancement Research Initiative","doi-asserted-by":"publisher","award":["Project ESP #05-226"],"award-info":[{"award-number":["Project ESP #05-226"]}],"id":[{"id":"10.13039\/100007181","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Syst Rev"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Antiplatelet agents are central in the management of vascular disease. The use of dual antiplatelet therapy (DAPT) for the management of thromboembolic complications must be weighed against bleeding risk in the perioperative setting. This balance is critical in patients undergoing cardiac or non-cardiac surgery. The management of patients on DAPT for any indication (including stents) is not clear and there is limited evidence to guide decision-making. This review summarizes current evidence since 2015 regarding the occurrence of major adverse events associated with continuing, suspending, or varying DAPT in the perioperative period.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A research librarian searched PubMed and Cochrane from November 30, 2015 to May 17, 2022, for relevant terms regarding adult patients on DAPT for any reason undergoing surgery, with a perioperative variation in DAPT strategy. Outcomes of interest included the occurrence of major adverse cardiac events, major adverse limb events, all-cause death, major bleeding, and reoperation. We considered withdrawal or discontinuation of DAPT as stopping either aspirin or a P2Y12 inhibitor or both agents; continuation of DAPT indicates that both drugs were given in the specified timeframe.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Eighteen observational studies met the inclusion criteria. No RCTs were identified, and no studies were judged to be at low risk of bias. Twelve studies reported on CABG. Withholding DAPT therapy for more than 2\u00a0days was associated with less blood loss and a slight trend favoring less transfusion and surgical re-exploration. Among five observational CABG studies, there were no statistically significant differences in patient death across DAPT management strategies. Few studies reported cardiac outcomes. The remaining studies, which were about procedures other than exclusively CABG, demonstrated mixed findings with respect to DAPT strategy, bleeding, and ischemic outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The evidence base on the benefits and risks of different perioperative DAPT strategies for patients with stents is extremely limited. The strongest signal, which was still judged as low certainty evidence, is that suspension of DAPT for greater than 2\u00a0days prior to CABG surgery is associated with less bleeding, transfusions, and re-explorations. Different DAPT strategies\u2019 association with other outcomes of interest, such as MACE, remains uncertain.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Systematic review registration<\/jats:title>\n                    <jats:p>\n                      A preregistered protocol for this review can be found on the PROSPERO International Prospective Register of systematic reviews (\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.crd.york.ac.uk\/PROSPERO\/\">http:\/\/www.crd.york.ac.uk\/PROSPERO\/<\/jats:ext-link>\n                      ; registration number: CRD42022371032).\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13643-023-02360-9","type":"journal-article","created":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T02:01:38Z","timestamp":1697248898000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Dual antiplatelet management in the perioperative period: updated and expanded systematic review"],"prefix":"10.1186","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0326-3717","authenticated-orcid":false,"given":"Alykhan M.","family":"Premji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariah B.","family":"Blegen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyssa M.","family":"Corley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesus","family":"Ulloa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marika S.","family":"Booth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meron","family":"Begashaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jody","family":"Larkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Shekelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark D.","family":"Girgis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melinda","family":"Maggard-Gibbons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,14]]},"reference":[{"issue":"6","key":"2360_CR1","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.jcin.2010.04.008","volume":"3","author":"NR Desai","year":"2010","unstructured":"Desai NR, Bhatt DL. The state of periprocedural antiplatelet therapy after recent trials. JACC Cardiovasc Interv. 2010;3(6):571\u201383.","journal-title":"JACC Cardiovasc Interv"},{"issue":"10","key":"2360_CR2","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/nrcardio.2011.96","volume":"8","author":"O Yousuf","year":"2011","unstructured":"Yousuf O, Bhatt DL. The evolution of antiplatelet therapy in cardiovascular disease. Nat Rev Cardiol. 2011;8(10):547\u201359.","journal-title":"Nat Rev Cardiol"},{"issue":"19","key":"2360_CR3","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1001\/jama.288.19.2411","volume":"288","author":"SR Steinhubl","year":"2002","unstructured":"Steinhubl SR, Berger PB, Mann JT 3rd, Fry ET, DeLago A, Wilmer C, et al. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA. 2002;288(19):2411\u201320.","journal-title":"JAMA"},{"issue":"7","key":"2360_CR4","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1056\/NEJMoa010746","volume":"345","author":"S Yusuf","year":"2001","unstructured":"Yusuf S, Zhao F, Mehta SR, Chrolavicius S, Tognoni G, Fox KK, et al. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med. 2001;345(7):494\u2013502.","journal-title":"N Engl J Med"},{"issue":"6","key":"2360_CR5","doi-asserted-by":"publisher","first-page":"e217","DOI":"10.1161\/STROKEAHA.120.033033","volume":"52","author":"K Bhatia","year":"2021","unstructured":"Bhatia K, Jain V, Aggarwal D, Vaduganathan M, Arora S, Hussain Z, et al. Dual antiplatelet therapy versus aspirin in patients with stroke or transient ischemic attack: meta-analysis of randomized controlled trials. Stroke. 2021;52(6):e217\u201323.","journal-title":"Stroke"},{"issue":"6","key":"2360_CR6","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1016\/j.jvs.2016.05.098","volume":"64","author":"PA Soden","year":"2016","unstructured":"Soden PA, Zettervall SL, Ultee KH, Landon BE, O\u2019Malley AJ, Goodney PP, et al. Dual antiplatelet therapy is associated with prolonged survival after lower extremity revascularization. J Vasc Surg. 2016;64(6):1633-44.e1.","journal-title":"J Vasc Surg"},{"issue":"2","key":"2360_CR7","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.ejvs.2016.04.023","volume":"52","author":"SM PeetersWeem","year":"2016","unstructured":"PeetersWeem SM, van Haelst ST, den Ruijter HM, Moll FL, de Borst GJ. Lack of evidence for dual antiplatelet therapy after endovascular arterial procedures: a meta-analysis. Eur J Vasc Endovasc Surg. 2016;52(2):253\u201362.","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"11","key":"2360_CR8","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1111\/j.1538-7836.2011.04456.x","volume":"9","author":"S Savonitto","year":"2011","unstructured":"Savonitto S, Caracciolo M, Cattaneo M, S DES. Management of patients with recently implanted coronary stents on dual antiplatelet therapy who need to undergo major surgery. J Thromb Haemost. 2011;9(11):2133\u201342.","journal-title":"J Thromb Haemost."},{"issue":"2","key":"2360_CR9","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1161\/CIRCINTERVENTIONS.111.963728","volume":"5","author":"A Tokushige","year":"2012","unstructured":"Tokushige A, Shiomi H, Morimoto T, Furukawa Y, Nakagawa Y, Kadota K, et al. Incidence and outcome of surgical procedures after coronary bare-metal and drug-eluting stent implantation: a report from the CREDO-Kyoto PCI\/CABG registry cohort-2. Circ Cardiovasc Interv. 2012;5(2):237\u201346.","journal-title":"Circ Cardiovasc Interv"},{"issue":"3","key":"2360_CR10","first-page":"E18","volume":"145","author":"JS Lawton","year":"2022","unstructured":"Lawton JS, Tamis-Holland JE, Bangalore S, Bates ER, Beckie TM, Bischoff JM, et al. 2021 ACC\/AHA\/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022;145(3):E18\u2013114.","journal-title":"Circulation"},{"issue":"3","key":"2360_CR11","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1093\/eurheartj\/ehx419","volume":"39","author":"M Valgimigli","year":"2018","unstructured":"Valgimigli M, Bueno H, Byrne RA, Collet JP, Costa F, Jeppsson A, et al. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2018;39(3):213\u201360.","journal-title":"Eur Heart J"},{"issue":"10","key":"2360_CR12","doi-asserted-by":"crossref","first-page":"e123","DOI":"10.1161\/CIR.0000000000000404","volume":"134","author":"GN Levine","year":"2016","unstructured":"Levine GN, Bates ER, Bittl JA, Brindis RG, Fihn SD, Fleisher LA, et al. 2016 ACC\/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines: An Update of the 2011 ACCF\/AHA\/SCAI Guideline for Percutaneous Coronary Intervention, 2011 ACCF\/AHA Guideline for Coronary Artery Bypass Graft Surgery, 2012 ACC\/AHA\/ACP\/AATS\/PCNA\/SCAI\/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease, 2013 ACCF\/AHA Guideline for the Management of ST-Elevation Myocardial Infarction, 2014 AHA\/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes, and 2014 ACC\/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery. Circulation. 2016;134(10):e123\u201355.","journal-title":"Circulation"},{"key":"2360_CR13","volume-title":"Management of antiplatelet therapy among patients on antiplatelet therapy for coronary or cerebrovascular disease or with prior percutaneous cardiac interventions undergoing elective surgery: a systematic review","author":"M Maggard Gibbons","year":"2017","unstructured":"Maggard Gibbons M, Ulloa JG, Macqueen IT, Childers CP, Miake-Lye IM, Shanman R, et al. Management of antiplatelet therapy among patients on antiplatelet therapy for coronary or cerebrovascular disease or with prior percutaneous cardiac interventions undergoing elective surgery: a systematic review. Washington (DC): VA Evidence-based Synthesis Program Reports; 2017."},{"issue":"1","key":"2360_CR14","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13643-017-0635-z","volume":"7","author":"CP Childers","year":"2018","unstructured":"Childers CP, Maggard-Gibbons M, Ulloa JG, MacQueen IT, Miake-Lye IM, Shanman R, et al. Perioperative management of antiplatelet therapy in patients undergoing non-cardiac surgery following coronary stent placement: a systematic review. Syst Rev. 2018;7(1):4.","journal-title":"Syst Rev"},{"issue":"2","key":"2360_CR15","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1001\/jama.2017.7845","volume":"318","author":"CP Childers","year":"2017","unstructured":"Childers CP, Maggard-Gibbons M, Shekelle PG. Antiplatelet Therapy in Patients With Coronary Stents Undergoing Elective Noncardiac Surgery: Continue, Stop, or Something in Between? JAMA. 2017;318(2):120\u20131.","journal-title":"JAMA"},{"key":"2360_CR16","volume-title":"Management of antiplatelet therapy among patients on antiplatelet therapy for cerebrovascular or peripheral vascular diseases undergoing elective non-cardiac surgery","author":"CP Childers","year":"2017","unstructured":"Childers CP, Mak S, Miake-Lye IM, O\u2019Neill SM, Shanman R, Beroes JM, et al. Management of antiplatelet therapy among patients on antiplatelet therapy for cerebrovascular or peripheral vascular diseases undergoing elective non-cardiac surgery. Washington (DC): VA Evidence-based Synthesis Program Reports; 2017."},{"key":"2360_CR17","unstructured":"Shekelle P M-GM, Girgis MD, et al. Dual antiplatelet management in the perioperative period: a systematic review. In press. Washington, DC: Evidence Synthesis Program: Health Services Research and Development Service, Office of Research and Development, Department of Veterans Affairs;2023."},{"issue":"372","key":"2360_CR18","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"2021","author":"MJMJ Page","year":"2021","unstructured":"Page MJMJ, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;2021(372):n71.","journal-title":"BMJ"},{"key":"2360_CR19","doi-asserted-by":"publisher","first-page":"i4919","DOI":"10.1136\/bmj.i4919","volume":"355","author":"JA Sterne","year":"2016","unstructured":"Sterne JA, Hernan MA, Reeves BC, Savovic J, Berkman ND, Viswanathan M, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;355:i4919.","journal-title":"BMJ"},{"key":"2360_CR20","unstructured":"The GRADE Working Group. 2022. Available from: https:\/\/www.gradeworkinggroup.org\/."},{"issue":"10","key":"2360_CR21","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1097\/BOT.0000000000001779","volume":"34","author":"SM Tarrant","year":"2020","unstructured":"Tarrant SM, Kim RG, McGregor KL, Palazzi K, Attia J, Balogh ZJ. Dual Antiplatelet Therapy and Surgical Timing in Geriatric Hip Fracture. J Orthop Trauma. 2020;34(10):559\u201365.","journal-title":"J Orthop Trauma"},{"issue":"4","key":"2360_CR22","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1093\/ejcts\/ezy355","volume":"55","author":"M Kremke","year":"2019","unstructured":"Kremke M, Gissel MS, Jensen MJ, Thomassen SA, Jakobsen CJ. The association between a three-day ticagrelor discontinuation and perioperative bleeding complications. Eur J Cardiothorac Surg. 2019;55(4):714\u201320.","journal-title":"Eur J Cardiothorac Surg"},{"issue":"3","key":"2360_CR23","first-page":"145","volume":"18","author":"P Nardi","year":"2021","unstructured":"Nardi P, Pisano C, Turturici M, Bertoldo F, Maggio VR, Bassano C, et al. The impact of dual antiplatelet therapy administration on the risk of bleeding complications during coronary artery bypass surgery. Kardiochir Torakochirurgia Pol. 2021;18(3):145\u201351.","journal-title":"Kardiochir Torakochirurgia Pol"},{"issue":"5","key":"2360_CR24","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1093\/ejcts\/ezx181","volume":"52","author":"A Della Corte","year":"2017","unstructured":"Della Corte A, Bancone C, Spadafora A, Borrelli M, Galdieri N, Quintiliano SN, et al. Postoperative bleeding in coronary artery bypass patients on double antiplatelet therapy: predictive value of preoperative aggregometry. Eur J Cardiothorac Surg. 2017;52(5):901\u20138.","journal-title":"Eur J Cardiothorac Surg"},{"issue":"1","key":"2360_CR25","first-page":"59","volume":"33","author":"SM Kacar","year":"2018","unstructured":"Kacar SM, Mikic A, Ka\u010dar MB. Postoperative Bleeding Following Preoperative Clopidogrel Administration in Patients with Haemoglobin Level Above 110 g\/L Undergoing Urgent CABG. Braz J Cardiovasc Surg. 2018;33(1):59\u201363.","journal-title":"Braz J Cardiovasc Surg"},{"issue":"10","key":"2360_CR26","doi-asserted-by":"publisher","first-page":"3154","DOI":"10.53350\/pjmhs2115103154","volume":"15","author":"M Shahid","year":"2021","unstructured":"Shahid M, Islam MU, Ahmad I, Khan B, Ali FA, Ahmed N, et al. Post operative complications associated with preoperative use of clopidogrel in patients undergoning coronary artery bypass surgery. Pakistan J Med Health Sci. 2021;15(10):3154\u20136.","journal-title":"Pakistan J Med Health Sci"},{"issue":"3","key":"2360_CR27","first-page":"164","volume":"5","author":"A Heidari","year":"2016","unstructured":"Heidari A, Dezfouli FG, Tabatabi K, Mali S, Ahang R, Latifi SM, et al. Combined clopidogrel and aspirin treatment up to surgery dosen\u2019t increase the risk of postoperative blood loss and reoperation for bleeding in patients undergoing coronary artery bypass grafting. Int J Pharm Res Allied Sci. 2016;5(3):164\u20137.","journal-title":"Int J Pharm Res Allied Sci"},{"issue":"8","key":"2360_CR28","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1111\/aas.13377","volume":"63","author":"H Irie","year":"2019","unstructured":"Irie H, Kawai K, Otake T, Shinjo Y, Kuriyama A, Yamashita S. Outcomes of patients on dual antiplatelet therapy post-coronary stenting following emergency noncardiac surgery. Acta Anaesthesiol Scand. 2019;63(8):982\u201392.","journal-title":"Acta Anaesthesiol Scand"},{"issue":"2","key":"2360_CR29","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1007\/s11239-021-02539-8","volume":"53","author":"D Cao","year":"2022","unstructured":"Cao D, Levin MA, Sartori S, Claessen B, Roumeliotis A, Zhang Z, et al. Perioperative risk and antiplatelet management in patients undergoing non-cardiac surgery within 1 year of PCI. J Thromb Thrombolysis. 2022;53(2):380\u20139.","journal-title":"J Thromb Thrombolysis"},{"issue":"11","key":"2360_CR30","doi-asserted-by":"publisher","first-page":"e016218","DOI":"10.1161\/JAHA.119.016218","volume":"9","author":"C Kim","year":"2020","unstructured":"Kim C, Kim JS, Kim H, Ahn SG, Cho S, Lee OH, et al. Patterns of antiplatelet therapy during noncardiac surgery in patients with second-generation drug-eluting stents. J Am Heart Assoc. 2020;9(11):e016218.","journal-title":"J Am Heart Assoc"},{"issue":"6","key":"2360_CR31","first-page":"391","volume":"18","author":"A Do\u011fan","year":"2017","unstructured":"Do\u011fan A, \u00d6zdemir E, Kahraman S, A\u00e7\u0131l T, Saltan Y, Kurto\u011flu N. Impact of early (3 months) dual antiplatelet treatment interruption prior to renal transplantation in patients with second-generation DES on perioperative stent thrombosis and MACEs. Anatol J Cardiol. 2017;18(6):391\u20136.","journal-title":"Anatol J Cardiol"},{"issue":"2","key":"2360_CR32","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1007\/s11239-020-02121-8","volume":"50","author":"P Cirillo","year":"2020","unstructured":"Cirillo P, Taglialatela V, Pellegrino G, Morello A, Conte S, Di Serafino L, et al. Effects of colchicine on platelet aggregation in patients on dual antiplatelet therapy with aspirin and clopidogrel. J Thromb Thrombolysis. 2020;50(2):468\u201372.","journal-title":"J Thromb Thrombolysis"}],"container-title":["Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-023-02360-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13643-023-02360-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-023-02360-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T09:46:13Z","timestamp":1700300773000},"score":1,"resource":{"primary":{"URL":"https:\/\/systematicreviewsjournal.biomedcentral.com\/articles\/10.1186\/s13643-023-02360-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,14]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2360"],"URL":"https:\/\/doi.org\/10.1186\/s13643-023-02360-9","relation":{},"ISSN":["2046-4053"],"issn-type":[{"value":"2046-4053","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,14]]},"assertion":[{"value":"24 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"197"}}